| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Medicine (Å.J., T.O.), Clinical Chemistry (Å.J.), and Clinical Genetics (K.Ce.), Umeå University Hospital, 901 85 Umeå; Department of Obstetrics and Gynecology and Clinical Research Center (K.Ca.), Karolinska Institute, Huddinge University Hospital, 141 86 Huddinge; Department of Medicine (B.A.), Malmö University Hospital, 205 02 Malmö; and Department of Internal Medicine (E.K., H.F.), Boden Hospital, 961 85 Boden, Sweden
Address correspondence and requests for reprints to: Åsa Johansson, Department of Clinical Chemistry, Umeå University Hospital, 901 85 Umeå, Sweden. E-mail: asa.johansson{at}medicin.umu.se
Metabolic-endocrine dysfunctions, including hyperinsulinemia,
hypertriglyceridemia, increased fat mass, and dysregulation of the
hypothalamic-pituitary-adrenal axis, are common in myotonic dystrophy
(MD). We hypothesized that increased production of interleukin-6 (IL-6)
and tumor necrosis factor-
(TNF-
) may be important underlying
mechanisms.
We studied the diurnal rhythmicity of cytokines and cortisol, ACTH, and dehydroepiandrosterone in 18 men with adult onset MD and 18 controls. Morning levels of androstenedione, 17-hydroxyprogesterone, testosterone, and insulin were also determined. Genetic analyses were performed, including calculation of allele sizes.
Median circulating 24-h levels of IL-6 (P <
0.001), TNF-
(P = 0.05), ACTH
(P < 0.05), and cortisol (P <
0.05) were all significantly increased in MD, whereas
dehydroepiandrosterone levels were decreased (P
< 0.001). The diurnal rhythms of these cytokines/hormones were
disturbed in patients. Morning testosterone levels were decreased and
insulin levels increased (P < 0.01 for both).
Patients with high body fat mass had significantly increased
insulin levels and decreased morning levels of cortisol, ACTH, and
testosterone.
IL-6 and TNF-
levels are increased and adrenocortical hormone
regulation is disturbed in MD. Adiposity may contribute to these
disturbances, which may be of importance for decreased adrenal androgen
hormone production and metabolic, muscular, and neuropsychiatric
dysfunction in MD.
This article has been cited by other articles:
![]() |
L. Zhang, J. E. Lee, J. Wilusz, and C. J. Wilusz The RNA-binding Protein CUGBP1 Regulates Stability of Tumor Necrosis Factor mRNA in Muscle Cells: IMPLICATIONS FOR MYOTONIC DYSTROPHY J. Biol. Chem., August 15, 2008; 283(33): 22457 - 22463. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Johansson, R. Andrew, H. Forsberg, K. Cederquist, B. R. Walker, and T. Olsson Glucocorticoid Metabolism and Adrenocortical Reactivity to ACTH in Myotonic Dystrophy J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4276 - 4283. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |